Pharmaceutical companies are reluctant to invest in production of new vaccines, owing to very less returns.

Re-Mark

MOHITCMI

9 Boards 28 Marks 0 Likes 0 Followers 0 Following 0 Unfollowers 15 views

Marked 5 years 11 months ago onto Pneumococcal Vaccines Market to Surpass US$ 13,194.3 Million by 2026

Pneumococcal Vaccines Market Analysis & Outlook By Leading Players Pfizer, Inc., Merck & Co. Inc., and GlaxoSmithKline plc. - openPR

Source: https://www.openpr.com/news/1427662

Pharmaceutical companies are reluctant to invest in production of new vaccines, owing to very less returns.

Report Mark

Report This Pin as Inappropriate

Please select the category that most closely reflects your concern about the Pin, so that we can review it and determine if it violates our Community Guidelines or isn't appropriate for all viewers. Abusing this feature is also a violation of the Community Guidelines, so don't do it.